Who is sponsoring NCT04467567?

NCT04467567 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT04467567?

Interventions in NCT04467567: Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT).

Is NCT04467567 still recruiting?

NCT04467567 is currently completed. Last updated 9 February 2024.

Last reviewed 2024-02-09 · How we verify

NCT04467567: EVADOVE177Lu

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dosimetry Using a CZT-camera Following LUTATHERA® Therapy

Completed NA Last updated 9 February 2024

What this trial tests

NA trial testing Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT) in Dosimetry in 15 participants. Completed in 24 July 2023.

Timeline

27 November 2020

Primary endpoint
25 March 2021

24 July 2023

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	15
Start date	27 November 2020
Primary completion	25 March 2021
Estimated completion	24 July 2023
Sites	1 location across France

Drugs / interventions tested

Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)

Conditions studied

Dosimetry — all drugs for Dosimetry →

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, any sex, with Dosimetry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the consistency between a dosimetry protocol using a large field of view CZT-camera and the dosimetry protocol used for recordings acquired with a conventional camera. Therefore, with the conventional camera, recordings are acquired on the "high energy" peak of lutetium 177 (208 keV) using a medium energy collimator. With the VERITON-CT™ CZT camera, recordings are acquired using the low energy peak of 113 keV. A second objective is to compare results between the dosimetry calculated using 3 measurement points (24h, 96h and 168h) and the dosimetry calculated using 2 measurement points (24h and 168h), obtained from the SYMBIA T conventional camera and the VERITON-CT™camera, respectively.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?
Vergnaud L, Dewaraja YK, Giraudet AL, Badel JN, et al · · 2024 · cited 14× · PMID 39023648 · DOI 10.1186/s40658-024-00658-8
Peptide Receptor Radionuclide Therapy with [<sup>177</sup>Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.
Del Olmo-García MI, Prado-Wohlwend S, Bello P, Segura A, et al · · 2022 · cited 14× · PMID 35158852 · DOI 10.3390/cancers14030584

Verify or expand the search:

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04467567 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 9 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04467567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing